Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The R3H domain and coiled-coil containing 1-like pseudogene (ENSG00000270807), abbreviated as R3HCC1L pseudogene, is classified as a pseudogene according to resources such as Ensembl and GeneCards[1][2][4]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode functional proteins and are not considered therapeutic targets. There is no known therapeutic or biomarker role for this pseudogene, and it is not associated with drug interactions, molecular functions, or disease involvement. Consequently, it should not be considered a valid molecular target for drug development or clinical purposes[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on R3H domain and coiled-coil containing 1-like pseudogene (R3HCC1L pseudogene).